Ronald McCord

Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes

Matthias Pfeifer, Bing Zheng, Tabea Erdmann et al. · Leukemia · 2015 · 152 citations

Pharmacy, Oncology, Pharmacology +10

Communication assessment using the common ground instrument: psychometric properties.

Forrest Lang, Ronald McCord, Delia Anderson · PubMed · 2004 · 118 citations

Social Sciences, Educational Assessment, Medical Education +17

PD-L1 and tumor-associated macrophages in de novo DLBCL

Ronald McCord, Christopher R. Bolen, Hartmut Koeppen et al. · Blood Advances · 2019 · 81 citations · Full text

Life Sciences, Hematology, Immunology +17

Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets

Christopher R. Bolen, Ronald McCord, Sarah Huet et al. · Blood Advances · 2017 · 61 citations · Full text

Life Sciences, Immunology, Oncology +16

Mosunetuzumab, a Novel CD20/CD3 Bispecific Antibody, in Combination with CHOP Confers High Response Rates in Patients with Diffuse Large B-Cell Lymphoma

Tycel Phillips, Adam J. Olszewski, Javier Muñoz et al. · Blood · 2020 · 45 citations

Medicine, Hematology, Oncology +16